Population Structure Analysis of Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates from Brazil Reveals Predominance of Clonal Complexes 1, 15, and 79

Antimicrobial Agents and Chemotherapy
Carlos Henrique CamargoDoroti de Oliveira Garcia

Abstract

The population structure of 71 carbapenem-resistantAcinetobacter baumanniiclinical isolates from several hospitals in Brazil was investigated by ApaI pulsed-field gel electrophoresis,blaOXA-51-like subtyping, and multilocus sequence typing (Institute Pasteur scheme). In addition to the predominance of strains carryingblaOXA-23, we detected the presence ofblaOXA-72andblaOXA-231 We observed a predominance of clonal complex 1 (CC1), CC15, and CC79 and representative strains of the worldwide-disseminated international clone I.

References

Feb 3, 2005·FEMS Microbiology Letters·Heidi SegalB Gay Elisha
Sep 29, 2005·Antimicrobial Agents and Chemotherapy·Claire HéritierPatrice Nordmann
Mar 28, 2006·International Journal of Antimicrobial Agents·Neil WoodfordDavid M Livermore
Sep 23, 2009·Antimicrobial Agents and Chemotherapy·Paul G HigginsHarald Seifert
Nov 6, 2010·The Journal of Antimicrobial Chemotherapy·Filipa GrossoLuísa Peixe
Mar 15, 2011·Diagnostic Microbiology and Infectious Disease·Laurent PoirelPatrice Nordmann
Apr 7, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Flávia Rossi
Nov 7, 2012·International Journal of Antimicrobial Agents·Raffaele ZarrilliAthanassios Tsakris
Jan 23, 2013·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Natacha MartinsBeatriz Meurer Moreira
Feb 13, 2013·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·T Coelho-SouzaB M Moreira
Oct 15, 2013·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Natacha MartinsBeatriz Meurer Moreira
Jun 2, 2014·Diagnostic Microbiology and Infectious Disease·Thiago Pavoni Gomes ChagasMarise Dutra Asensi
Jun 4, 2014·Antimicrobial Agents and Chemotherapy·Rodrigo CayôLuis Martínez-Martínez
Oct 8, 2014·Antimicrobial Agents and Chemotherapy·Marcelo PillonettoMarise Dutra Asensi
Sep 14, 2015·Diagnostic Microbiology and Infectious Disease·Ana Tereza R VasconcelosWillames M B S Martins

❮ Previous
Next ❯

Citations

Dec 7, 2016·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Mariana PaganoAfonso L Barth
Jan 6, 2017·Journal of Medical Microbiology·Francielli Mahnic de VasconcellosCarlos Henrique Camargo
Jun 2, 2017·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Adriana CorreaMaría V Villegas
Nov 9, 2018·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Mariana PaganoAndreza F Martins
Jul 5, 2018·Emerging Microbes & Infections·Saúl Levy-BlitchteinJordi Vila
Nov 30, 2019·Memórias do Instituto Oswaldo Cruz·Raquel Vosges CaldartAna Carolina Vicente
Jan 22, 2019·Frontiers in Microbiology·Laís Calissi Brisolla TavaresCarlos Henrique Camargo
Oct 13, 2020·International Journal of Antimicrobial Agents·Carlos Henrique CamargoMonique Ribeiro Tiba-Casas
Nov 12, 2020·Revista Da Sociedade Brasileira De Medicina Tropical·Mariana Neri Lucas KuriharaSimone Simionatto

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.